9pcq
Phosphorylation of a Conserved Aspartate at the Eukaryotic Elongation Factor 2 Kinase Catalytic Site
Structural highlights
FunctionEF2K_HUMAN Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced.[1] [2] Publication Abstract from PubMedEukaryotic elongation factor 2 kinase (eEF-2K) is a member of the alpha-kinase family of atypical serine/threonine kinases. eEF-2K, the only calmodulin-activated alpha-kinase, phosphorylates the ribosome-associated GTPase, eukaryotic elongation factor 2 (eEF-2), suppressing translational elongation. alpha-kinases, including eEF-2K, possess catalytic site geometries that are distinct from those of typical kinases, suggesting possible divergence in their phospho-transfer mechanisms. Unlike typical protein kinases, where chemistry is known to proceed through a sequential mechanism involving a ternary kinase-substrate-ATP*Mg(2+) complex, the nature of the chemical step catalyzed by alpha-kinases remains poorly defined. Here, multiple orthogonal lines of evidence, including a crystal structure and solution-state mass spectrometry data, suggest phosphorylation of a catalytically essential aspartate residue (D284) at the eEF-2K active site. Previous crystallographic evidence of the presence of a phospho-aspartate at an equivalent position (D766) in the related Dictyostelium alpha-kinase MHCK-A strongly suggests that this species represents a conserved active-site feature in alpha-kinase family members, despite their disparate modes of activation. This observation, together with existing kinetics data on eEF-2K, raises the possibility that phospho-transfer chemistry in alpha-kinases occurs via an ordered stepwise mechanism involving a phospho-enzyme intermediate, contrasting with typical protein kinases. Phosphorylation of a conserved aspartate in the catalytic site of eukaryotic elongation factor 2 kinase.,Piserchio A, Isiorho EA, Abzalimov R, Dalby KN, Ghose R Protein Sci. 2026 Jan;35(1):e70442. doi: 10.1002/pro.70442. PMID:41432361[3] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
| ||||||||||||||||||||
